Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Mayo Clin Proc. 2014 Jun 27;89(11):1515–1524. doi: 10.1016/j.mayocp.2014.04.015

Table 4.

Incidence of Leukocytoclastic Vasculitis in Olmsted County, Minnesota, 1996–2010

Female Patients Male Patients Total
Age at diagnosis, y No. Rate (95% CI)a No. Rate (95% CI)a No. Rate (95% CI)a
0–19 6 2.2 (0.8–4.8) 1 0.3 (0.0–1.9) 7 1.2 (0.5–2.6)
20–29 3 2.2 (0.5–6.5) 6 4.7 (1.7–10.2) 9 3.4 (1.6–6.5)
30–39 4 2.7 (0.7–6.9) 3 2.0 (0.4–5.8) 7 2.3 (0.9–4.8)
40–49 10 6.7 (3.2–12.3) 10 6.8 (3.3–12.6) 20 6.8 (4.1–10.5)
50–59 10 8.4 (4.0–15.4) 7 6.2 (2.5–12.7) 17 7.3 (4.3–11.7)
60–69 7 9.3 (3.7–19.2) 7 10.2 (4.1–21.0) 14 9.7 (5.3–16.3)
≥70 3 3.1 (0.6–9.1) 7 10.9 (4.4–22.5) 10 6.2 (3.0–11.5)
Year of diagnosis No. Rate (95% CI)b No. Rate (95% CI)b No. Rate (95% CI)c
1996–2000 13 4.4 (2.0–6.8) 8 3.2 (0.9–5.6) 21 3.7 (2.1–5.3)
2001–2005 13 4.0 (1.8–6.1) 16 5.4 (2.7–8.1) 29 4.6 (2.9–6.3)
2006–2010 17 4.8 (2.5–7.0) 17 5.3 (2.8–7.9) 34 5.0 (3.3–6.7)
LCV subtyped No. Rate (95% CI)b No. Rate (95% CI)b No. Rate (95% CI)c
All CSVV 19 1.9 (1.1–2.8) 19 2.3 (1.3–3.4) 38 2.1 (1.4–2.7)
Idiopathic CSVV 16 1.6 (0.8–2.4) 13 1.6 (0.7–2.6) 29 1.6 (1.0–2.1)
IgA vasculitis 11 1.1 (0.4–1.7) 14 1.6 (0.7–2.4) 25 1.3 (0.8–1.8)
Urticarial vasculitis 9 0.9 (0.3–1.5) 1 0.1 (0.0–0.3) 10 0.5 (0.2–0.8)
ANCA-associated 3 0.3 (0.0–0.7) 5 0.5 (0.1–1.0) 8 0.4 (0.1–0.7)
All patients 43 4.4 (3.1–5.7) 41 4.8 (3.3–6.2) 84 4.5 (3.5–5.4)

Abbreviations: ANCA, antineutrophil cytoplasmic antibody; CI, confidence interval, CSVV, cutaneous small-vessel vasculitis; LCV, leukocytoclastic vasculitis.

a

Incidence per 100,000 person-years.

b

Incidence per 100,000 person-years age-adjusted to 2000 US white population.

c

Incidence per 100,000 person-years age- and sex-adjusted to 2000 US white population.

d

Age- and sex-adjusted incidence was not calculated for cryoglobulinemic vasculitis because this subgroup included only 3 patients.